搜索筛选:
搜索耗时5.8959秒,为你在为你在102,285,761篇论文里面共找到 3 篇相符的论文内容
发布年度:
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction
[期刊论文] 作者：Zahariy Krastev,Deian Jelev,Kr,
来源：世界胃肠病学杂志：英文版 年份：2016
We observed a sustained viral response(SVR) of ombitasvir/paritaprevir/ritonavir, dasabuvir and ribavirin therapy, for 12 wk, in two cases with compensated live...
[期刊论文] 作者：Zahari Krastev,Deian Jelev,Donika Krasteva,Jordan Genov,Teodora Komitova,
来源：肝癌研究（英文版） 年份：2019
Chronic hepatitis C virus (HCV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma (HCC) worldwide. The recent advancement of direct-act...
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction
[期刊论文] 作者：Zahariy Krastev,Deian Jelev,Krasimir Antonov,Tanya Petkova,Evelina Atanasova,Nadezhda Zheleva,Bojidar,
来源：World Journal of Gastroenterology 年份：2016
We observed a sustained viral response(SVR) of ombitasvir/paritaprevir/ritonavir, dasabuvir and ribavirin therapy, for 12 wk, in two cases with compensated live...
相关搜索：
